Tag: The Lancet
TENSION results show improved functional outcomes and reduced mortality with stroke...
New results from the TENSION study—presented recently at the 15th World Stroke Congress (WSC; 10–12 October, Toronto, Canada) by Götz Thomalla (University Medical Center...
‘Minimal differences’ in clinical outcomes between stroke thrombectomy with or without...
There are likely to be minimal differences in clinical outcomes between acute stroke patients presenting directly to endovascular treatment centres who undergo mechanical thrombectomy...
MR CLEAN-LATE trial finds endovascular therapy safe and effective in late-presenting...
Endovascular therapy (EVT) has been deemed safe and effective in patients with ischaemic stroke caused by an anterior circulation large-vessel occlusion (LVO) who present...
Chinese TRACE II trial deems tenecteplase non-inferior to alteplase in ischaemic...
New data on intravenous tenecteplase indicate that it can achieve comparable efficacy and safety to alteplase in treating stroke—and, as such, may be used...
ENCHANTED2/MT data indicate intensive blood pressure lowering “should be avoided” after...
Recently published data from the ENCHANTED2/MT study have shed new light on the safety and efficacy of more intensive versus less intensive blood pressure...
Study reveals racial disparity in brain tumour surgeries recommended to US...
A patient’s race may influence the recommendations they receive for the surgical removal of brain tumours, as per a recent, registry-based cohort analysis published...
Direct thrombectomy fails to show non-inferiority versus bridging therapy in early...
The international DIRECT-SAFE trial has produced results indicating that intravenous thrombolysis (IVT) plus mechanical thrombectomy—commonly referred to as bridging therapy—should continue to be recommended...
Tenecteplase offers “incredible opportunity” to optimise thrombolytic stroke treatments
Earlier this year, results from the Canadian AcT (Alteplase compared to tenecteplase) randomised controlled trial (RCT) were delivered for the first time at the...
Tenecteplase shown to be effective for acute ischaemic stroke in large...
In what is claimed to be the largest stroke clinical trial ever run in Canada, researchers have shown that tenecteplase—a safe, well-tolerated drug commonly...
MicroTransponder gains FDA approval for first-of-its-kind VNS system to improve stroke...
MicroTransponder has announced US Food and Drug Administration (FDA) premarket approval of the Vivistim paired vagus nerve stimulation (VNS) system, which—according to a company...
